Cancer Treatment
Notice to user: The term chemotherapy, later shortened to “chemo”, originated in the early 1900s from Nobel Prize winning German physician and chemist, Dr. Paul Erlich. Dr. Erlich defined chemotherapy to mean “the use of chemicals as a therapy to treat disease.” (Source). Many years later, the term became synonymous with the use of chemicals to treat cancer specifically. Because early cancer therapies became quickly known for their severe side effect profile, the term chemotherapy took on a negative connotation. If we fast forward several decades, the anti-cancer therapies used today have become refined, and for many diseases, treatment can be safely taken in the comfort of your own home.
As chemotherapy has become particularly targeted, certain side effects have lessened, while new side effects have emerged. However, the premise behind therapy, that is using a chemical to kill cancer, has not changed. Therefore, the clinicians who created ChemoExperts.com believe the term “chemotherapy” still very much applies to all anti-cancer medications, but importantly, can no longer suggest what, if any, side effects a patient is likely to experience. For this to become clear, education regarding each individual drug, as well as information derived from the use of combination therapy (multiple chemo medications) is required. As a result, we have structured our website to make it easier for users to learn about cancer treatment and hope that if you are taking or receiving chemotherapy, that ChemoExperts.com is able to provide you with the tools needed to make the journey a little easier and life more rewarding.
To learn more, please choose a Treatment below.
NOTE: Treatment Options listed are not all-inclusive. Other treatments may be available. ChemoExperts does not recommend any one treatment over another. Only your Doctor can decide this.
- 7 + 3 (Cytarabine + Daunorubicin) for Acute Myeloid Leukemia (AML)
- 7 + 3 (Cytarabine + Daunorubicin) plus Midostaurin (Rydapt®) for Acute Myeloid Leukemia (AML)
- 7 + 3 (Cytarabine + Idarubicin) for Acute Myeloid Leukemia (AML)
- AAVD (Brentuximab vedotin, Doxorubicin, Vinblastine, Dacarbazine) for Hodgkin's Lymphoma (HL)
- ABCP (Atezolizumab (Tecentriq®) + Bevacizumab + Carboplatin + Paclitaxel) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Abemaciclib (Verzenio®) for Breast Cancer - metastatic
- Abemaciclib (Verzenio®) + Anastrozole (Arimidex®) for Breast Cancer - early stage
- Abemaciclib (Verzenio®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Abemaciclib (Verzenio®) + Letrozole (Femara®) for Breast Cancer - early stage
- Abemaciclib (Verzenio®) + Tamoxifen for Breast Cancer - early stage
- Abiraterone (Zytiga®) + Prednisone for Prostate Cancer
- Abraxane® (Paclitaxel protein-bound) for Breast Cancer - metastatic
- Abraxane® (Paclitaxel protein-bound) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- ABVD (Doxorubicin + Bleomycin + Vinblastine + Dacarbazine) for Hodgkin's Lymphoma (HL)
- AC (Adriamycin® + Cyclophosphamide) followed by THP (Taxol® + Herceptin® + Pertuzumab) for Breast Cancer - early stage
- Acalabrutinib (Calquence®) for Lymphoma, Mantle Cell
- Acalabrutinib (Calquence®) for Chronic Lymphocytic Leukemia (CLL)
- Acalabrutinib (Calquence®) + Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia (CLL)
- Ado-trastuzumab emtansine (Kadcyla®) for Breast Cancer - metastatic
- Afatinib (Gilotrif®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- AIM (Adriamycin® + Ifosfamide + Mesna) for Sarcoma
- Alectinib (Alecensa®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Alpelisib (Piqray®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Amivantamab (Rybrevant®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Amivantamab (Rybrevant®) + Carboplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Anagrelide (Agrylin®) for Essential Thrombocythemia
- Anastrozole (Arimidex®) for Breast Cancer - metastatic
- Anastrozole (Arimidex®) for Breast Cancer - early stage
- Antithymocyte Globulin (ATG, ATGAM®) + Cyclosporine (Gengraf®, Neoral®) for Severe Aplastic Anemia (SAA)
- Antithymocyte Globulin (ATG, ATGAM®) + Cyclosporine (Gengraf®, Neoral®) + Eltrombopag (Promacta®) for Severe Aplastic Anemia (SAA)
- Apixaban (Eliquis®) for Blood Clots
- Aprepitant (Emend®) for Nausea and Vomiting
- Asciminib (Scemblix®) for Chronic Myeloid Leukemia (CML)
- Atezolizumab (Tecentriq®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Atezolizumab (Tecentriq®) + Bevacizumab for Liver Cancer
- ATRA (Tretinoin) + Arsenic Trioxide (Trisenox®) for Acute Promyelocytic Leukemia (APL)
- ATRA (Tretinoin) + Arsenic Trioxide (Trisenox®) Consolidation for Acute Promyelocytic Leukemia (APL)
- Avapritinib (Ayvakit®) for Advanced Systemic Mastocytosis
- Avatrombopag (Doptelet®) for Immune Thrombocytopenic Purpura (ITP)
- Avelumab (Bavencio®) for Merkel Cell Carcinoma (MCC)
- Avelumab (Bavencio®) for Bladder Cancer
- Axitinib (Inlyta®) for Renal Cell Carcinoma - Kidney Cancer
- Axitinib (Inlyta®) + Pembrolizumab (Keytruda®) for Renal Cell Carcinoma - Kidney Cancer
- Azacitidine (Vidaza®) for Myelodysplastic Syndromes (MDS)
- Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- BCG (Bacillus Calmette-Guérin, Theracys®, TICE®) for Bladder Cancer
- BCP (Bevacizumab + Carboplatin + Paclitaxel) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- BEAM (Carmustine + Etoposide + Cytarabine + Melphalan) for Autologous Stem Cell Transplant (autoSCT)
- Bendamustine + Rituximab for Lymphoma, B-cell
- Bendamustine + Rituximab for Chronic Lymphocytic Leukemia (CLL)
- Bendamustine + Rituximab for Lymphoma, Mantle Cell
- BEP (Bleomycin + Etoposide + Cisplatin) 5-Day for Testicular Cancer
- BEP (Bleomycin + Etoposide + Cisplatin) 3-Day for Testicular Cancer
- Bevacizumab (Avastin®) for Ovarian Cancer
- Bevacizumab (Avastin®) + Temozolomide (Temodar®) for Brain Cancer
- Bexarotene (Targretin®) for Lymphoma, T-Cell
- Bicalutamide (Casodex®) for Prostate Cancer
- Bisacodyl (Dulcolax®) for Constipation
- Blinatumomab (Blincyto®) for Acute Lymphoid Leukemia (ALL)
- Bosutinib (Bosulif®) for Chronic Myeloid Leukemia (CML)
- Brentuximab Vedotin (Adcetris®) for Hodgkin's Lymphoma (HL)
- Brentuximab Vedotin (Adcetris®) for Lymphoma, T-Cell
- Brigatinib (Alunbrig®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- BV-CHP (Brentuximab Vedotin (Adcetris®) + Cyclophosphamide + Doxorubicin + Prednisone) for Lymphoma, T-Cell
- C10403 Consolidation for Acute Lymphoid Leukemia (ALL)
- C10403 Delayed Intensification for Acute Lymphoid Leukemia (ALL)
- C10403 Induction for Acute Lymphoid Leukemia (ALL)
- C10403 Interim Maintenance for Acute Lymphoid Leukemia (ALL)
- C10403 Maintenance for Acute Lymphoid Leukemia (ALL)
- Cabazitaxel (Jevtana®) + Prednisone for Prostate Cancer
- Cabozantinib (Cabometyx®) for Liver Cancer
- Cabozantinib (Cometriq®) for Thyroid Cancer
- Capecitabine (Xeloda®) for Breast Cancer - metastatic
- Capecitabine (Xeloda®) for Colon Cancer
- Capecitabine (Xeloda®) for Bile Duct Cancer
- Capecitabine (Xeloda®) + Oxaliplatin for Colon Cancer
- Capivasertib (Truqap®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Capmatinib (Tabrecta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Abraxane® (Paclitaxel protein-bound particles); for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Docetaxel (Carboplatin + Taxotere®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Docetaxel (Taxotere®) for Ovarian Cancer
- Carboplatin + Etoposide for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Etoposide (Carbo/Etop) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Carboplatin + Etoposide + Atezolizumab (Tecentriq®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Carboplatin + Fluorouracil + Cetuximab (Erbitux®) for Head and Neck Cancer
- Carboplatin + Gemcitabine (Gemzar®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Ovarian Cancer
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Uterine/Endometrial Cancer
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Breast Cancer - metastatic
- Carboplatin + Paclitaxel + Bevacizumab for Ovarian Cancer
- Carboplatin + Paclitaxel + Pembrolizumab (Keytruda®) followed by Cyclophosphamide + Doxorubicin + Pembrolizumab (Keytruda®) for Breast Cancer - early stage
- Carboplatin + Paclitaxel + Pembrolizumab (Keytruda®) for Uterine/Endometrial Cancer
- Carboplatin + Paclitaxel + Radiation for Esophageal Cancer
- Carboplatin + Paclitaxel + Radiation for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel + Radiation for Head and Neck Cancer
- Carboplatin + Pemetrexed (Alimta®) (Carbo/Pem) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carfilzomib (Kyprolis®) for Multiple Myeloma (MM)
- Cemiplimab (Libtayo®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Ceritinib (Zykadia®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cetuximab (Erbitux®) for Head and Neck Cancer
- CHOP (Cyclophosphamide + Doxorubicin + Vincristine + Prednisone) for Lymphoma, T-Cell
- Cisplatin (Platinol®) + Irinotecan (Camptosar®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Cisplatin + Docetaxel for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Etoposide for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Cisplatin + Etoposide for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Fluorouracil (5-FU) + Cetuximab (Erbitux®) for Head and Neck Cancer
- Cisplatin + Fluorouracil + Trastuzumab for Esophageal Cancer
- Cisplatin + Gemcitabine for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Gemcitabine for Bile Duct Cancer
- Cisplatin + Gemcitabine (Gemzar®) for Pancreatic Cancer
- Cisplatin + Gemcitabine + Durvalumab (Imfinzi®) for Bile Duct Cancer
- Cisplatin + Gemcitabine + Pembrolizumab (Keytruda®) for Bile Duct Cancer
- Cisplatin + Paclitaxel (Taxol®) for Cervical Cancer
- Cisplatin + Paclitaxel (Taxol®) + Bevacizumab for Cervical Cancer
- Cisplatin + Pemetrexed (Alimta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Radiation for Head and Neck Cancer
- Cisplatin + Radiation + Pembrolizumab (Keytruda®) for Cervical Cancer
- Cisplatin + Radiation followed by Carboplatin + Paclitaxel for Uterine/Endometrial Cancer
- Cisplatin + Vinblastine + Radiation for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Vinorelbine (Navelbine®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- CLAG-M (Cladribine + Cytarabine + G-CSF + Mitoxantrone) for Acute Myeloid Leukemia (AML)
- CRD (Carfilzomib + Revlimid® + Dexamethasone) for Multiple Myeloma (MM)
- Crizotinib (Xalkori®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- CyBorD (Cyclophosphamide + Bortezomib + Dexamethasone) for Multiple Myeloma (MM)
- DA-EPOCH-R (Dose Adjusted - Etoposide + Prednisone + Vincristine + Cyclophosphamide + Doxorubicin + Rituximab) for Lymphoma, B-cell
- Dabrafenib (Tafinlar®) + Trametinib (Mekinist®) for Melanoma
- Dabrafenib (Tafinlar®) + Trametinib (Mekinist®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Daratumumab (Darzalex®) for Multiple Myeloma (MM)
- Daratumumab and Hyaluronidase (Darzalex Faspro®) for Multiple Myeloma (MM)
- Dasatinib (Sprycel®) for Chronic Myeloid Leukemia (CML)
- Dasatinib (Sprycel®) for Acute Lymphoid Leukemia (ALL)
- Daunorubicin and cytarabine liposome (Vyxeos®) for Acute Myeloid Leukemia (AML)
- Decitabine (Dacogen®) for Myelodysplastic Syndromes (MDS)
- Decitabine (Dacogen®) for Acute Myeloid Leukemia (AML)
- Decitabine and Cedazuridine (Inqovi®) for Myelodysplastic Syndromes (MDS)
- Dexamethasone (Decadron®) for Immune Thrombocytopenic Purpura (ITP)
- Dexamethasone (Decadron®) for Nausea and Vomiting
- Diphenoxylate and atropine (Lomotil®) for Diarrhea
- Docetaxel (Taxotere®) + Ramucirumab (Cyramza®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Docetaxel (Taxotere®) + Prednisone for Prostate Cancer
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) for Breast Cancer - early stage
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) for Breast Cancer - early stage
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + Weekly Taxol® for Breast Cancer - early stage
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + Dose-Dense Taxol® for Breast Cancer - early stage
- Dose-Dense MVAC (DD-Methotrexate + Vinblastine + Adriamycin + Cisplatin) for Bladder Cancer
- Dostarlimab (Jemperli®) for Colon Cancer
- DPd (Daratumumab + Pomalidomide + Dexamethasone) for Multiple Myeloma (MM)
- DRd (Daratumumab + Revlimid® + dexamethasone) for Multiple Myeloma (MM)
- DRVd (Daratumumab + Revlimid® + Velcade® + dexamethasone) for Multiple Myeloma (MM)
- Durvalumab (Imfinzi®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Duvelisib (Copiktra®) for Chronic Lymphocytic Leukemia (CLL)
- DVd (Daratumumab + Velcade® (bortezomib) + dexamethasone) for Multiple Myeloma (MM)
- Elacestrant (Orserdu®) for Breast Cancer - metastatic
- Eltrombopag (Promacta®) for Immune Thrombocytopenic Purpura (ITP)
- Enasidenib (IDHIFA®) for Acute Myeloid Leukemia (AML)
- Encorafenib (Braftovi®) + Binimetinib (Mektovi®) for Melanoma
- Encorafenib (Braftovi®) + Cetuximab (Erbitux®) for Colon Cancer
- Enfortumab Vedotin (Padcev®) for Bladder Cancer
- Enfortumab Vedotin (Padcev®) + Pembrolizumab (Keytruda®) for Bladder Cancer
- Enoxaparin (Lovenox®) for Blood Clots
- Enzalutamide (Xtandi®) for Prostate Cancer
- ERd (Elotuzumab (Empliciti®) + Revlimid® + dexamethasone) for Multiple Myeloma (MM)
- Eribulin (Halaven®) for Breast Cancer - metastatic
- Erlotinib (Tarceva®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Everolimus (Afinitor®) for Renal Cell Carcinoma - Kidney Cancer
- Everolimus (Afinitor®) + Exemestane for Breast Cancer - metastatic
- fam-trastuzumab deruxtecan-nxki (Enhertu®) for Breast Cancer - metastatic
- FCR (Fludarabine + Cyclophosphamide + Rituximab) for Chronic Lymphocytic Leukemia (CLL)
- Fedratinib (Inrebic®) for Myelofibrosis
- Fentanyl (Duragesic®) for Pain
- Filgrastim (Neupogen®, Zarxio®, Nivestym®, Releuko®) for Neutropenic Fever
- FLAG-IDA (Fludarabine + Ara-C + G-CSF + Idarubicin) for Acute Myeloid Leukemia (AML)
- FLAG-IDA (Fludarabine + Ara-C + G-CSF + Idarubicin) for Acute Lymphoid Leukemia (ALL)
- FLOT (Fluorouracil + Leucovorin + Oxaliplatin + Docetaxel) for Stomach Cancer
- FLOT (Fluorouracil + Leucovorin + Oxaliplatin + Docetaxel) for Esophageal Cancer
- FOLFIRI (Folinic acid + Fluorouracil + Irinotecan) for Colon Cancer
- FOLFIRI (Folinic acid + Fluorouracil + Irinotecan) for Bile Duct Cancer
- FOLFIRI + Bevacizumab for Colon Cancer
- FOLFIRI + Cetuximab (Erbitux®) for Colon Cancer
- FOLFIRI + Panitumumab (Vectibix®) for Colon Cancer
- FOLFIRINOX (Fluorouracil + Leucovorin + Irinotecan + Oxaliplatin) for Pancreatic Cancer
- FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin) for Colon Cancer
- FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin) for Bile Duct Cancer
- FOLFOX + Bevacizumab for Colon Cancer
- FOLFOX + Cetuximab (Erbitux®) for Colon Cancer
- FOLFOX + Panitumumab (Vectibix®) for Colon Cancer
- Fosaprepitant (Emend®) for Nausea and Vomiting
- Fostamatinib (Tavalisse®) for Immune Thrombocytopenic Purpura (ITP)
- Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Gefitinib (Iressa®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Gemcitabine (Gemzar®) for Pancreatic Cancer
- Gemcitabine (Gemzar®) + Cisplatin for Bladder Cancer
- Gemcitabine (Gemzar®) + Docetaxel (Taxotere®) for Sarcoma
- Gemcitabine + Abraxane® for Pancreatic Cancer
- Gemcitabine + Abraxane® for Bile Duct Cancer
- Gemcitabine + Capecitabine (Xeloda®) for Pancreatic Cancer
- Gilteritinib (Xospata®) for Acute Myeloid Leukemia (AML)
- HiDAC (High Dose Ara-C) for Acute Myeloid Leukemia (AML)
- HiDAC (High Dose Ara-C) + Midostaurin (Rydapt®) for Acute Myeloid Leukemia (AML)
- Hydroxyurea (Hydrea®, Droxia®) for Polycythemia Vera
- Hydroxyurea (Hydrea®, Droxia®) for Essential Thrombocythemia
- HyperCVAD (Part A) for Acute Lymphoid Leukemia (ALL)
- HyperCVAD (Part B) for Acute Lymphoid Leukemia (ALL)
- IBR (Ibrutinib + Bendamustine + Rituximab) for Chronic Lymphocytic Leukemia (CLL)
- Ibrutinib (Imbruvica®) for Chronic Lymphocytic Leukemia (CLL)
- Idelalisib (Zydelig®) + Rituximab for Chronic Lymphocytic Leukemia (CLL)
- IE (Ifosfamide + Etoposide) for Sarcoma
- Imatinib (Gleevec®) for Chronic Myeloid Leukemia (CML)
- Imatinib (Gleevec®) for Gastrointestinal Stromal Tumor (GIST)
- Immune Globulin (IVIG, IV IgG) for Immune Thrombocytopenic Purpura (ITP)
- Inotuzumab Ozogamicin (Besponsa®) for Acute Lymphoid Leukemia (ALL)
- Intraperitoneal (IP) Cisplatin + IP Paclitaxel + Intravenous (IV) Paclitaxel for Ovarian Cancer
- IRd (Ixazomib + Revlimid® (lenalidomide) + dexamethasone) for Multiple Myeloma (MM)
- Isa-Pd (Isatuximab + Pomalidomide + Dexamethasone) for Multiple Myeloma (MM)
- Ivosidenib (Tibsovo®) for Acute Myeloid Leukemia (AML)
- Ivosidenib (Tibsovo®) + Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- Lactulose for Constipation
- Lapatinib (Tykerb®) + Capecitabine (Xeloda®) for Breast Cancer - metastatic
- Lenalidomide (Revlimid®) for Myelodysplastic Syndromes (MDS)
- Lenvatinib (Lenvima®) for Liver Cancer
- Lenvatinib (Lenvima®) + Pembrolizumab (Keytruda®) for Uterine/Endometrial Cancer
- Lenvatinib (Lenvima®) + Pembrolizumab (Keytruda®) for Renal Cell Carcinoma - Kidney Cancer
- Letrozole (Femara®) for Breast Cancer - early stage
- Letrozole (Femara®) for Breast Cancer - metastatic
- Leuprolide acetate (Lupron Depot®, Eligard®) for Prostate Cancer
- Liposomal Doxorubicin (Doxil®) for Sarcoma
- Liposomal Doxorubicin (Doxil®) for Ovarian Cancer
- Liposomal Doxorubicin (Doxil®) + Bevacizumab (Avastin®, Alymsys®, Mvasi®, Zirabev®) for Ovarian Cancer
- Liposomal Doxorubicin (Doxil®) + Carboplatin for Ovarian Cancer
- Loperamide (Imodium®) for Diarrhea
- Lorazepam (Ativan®) for Nausea and Vomiting
- Low-dose Cytarabine (LDAC) for Acute Myeloid Leukemia (AML)
- Lurbinectedin (Zepzelca®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Luspatercept (Reblozyl®) for Myelodysplastic Syndromes (MDS)
- Magnesium Citrate for Constipation
- MAP (Methotrexate + Doxorubicin + Cisplatin) for Sarcoma
- Margetuximab (Margenza®) + Capecitabine (Xeloda®) for Breast Cancer - metastatic
- Maxi-CHOP (also known as Nordic Regimen) for Lymphoma, Mantle Cell
- Melphalan (Evomela®, Alkeran®) for Autologous Stem Cell Transplant (autoSCT)
- Metoclopramide (Reglan®) for Nausea and Vomiting
- Midostaurin (Rydapt®) for Advanced Systemic Mastocytosis
- Mirvetuximab Soravtansine (Elahere®) for Ovarian Cancer
- Modified FOLFIRINOX (Fluorouracil + Leucovorin + Irinotecan + Oxaliplatin) for Pancreatic Cancer
- Morphine (MSIR, MS Contin®, Kadian®, Arymo® ER, MorphaBond ER®) for Pain
- Nelarabine (Arranon®) for Acute Lymphoid Leukemia (ALL)
- Neratinib (Nerlynx®) for Breast Cancer - early stage
- Nilotinib (Tasigna®) for Chronic Myeloid Leukemia (CML)
- Niraparib (Zejula®) for Ovarian Cancer
- Nivolumab (Opdivo®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Nivolumab (Opdivo®) for Melanoma
- Nivolumab (Opdivo®) for Head and Neck Cancer
- Nivolumab (Opdivo®) for Bladder Cancer
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Melanoma
- Nivolumab (Opdivo®) for Hodgkin's Lymphoma (HL)
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Colon Cancer
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Renal Cell Carcinoma - Kidney Cancer
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Liver Cancer
- Nivolumab + Relatlimab (Opdualag®) for Melanoma
- Olaparib (Lynparza®) for Ovarian Cancer
- Olaparib (Lynparza®) for Breast Cancer - metastatic
- Olaparib (Lynparza®) for Pancreatic Cancer
- Olaparib (Lynparza®) for Breast Cancer - early stage
- Olaparib (Lynparza®) + Abiraterone (Zytiga®) + Prednisone for Prostate Cancer
- Olaparib (Lynparza®) + Bevacizumab for Ovarian Cancer
- Olutasidenib (Rezlidhia®) for Acute Myeloid Leukemia (AML)
- Omacetaxine (Synribo®) for Chronic Myeloid Leukemia (CML)
- Ondansetron (Zofran®, Zofran ODT®) for Nausea and Vomiting
- Osimertinib (Tagrisso®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Osimertinib (Tagrisso®) + Carboplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Osimertinib (Tagrisso®) + Cisplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Oxycodone (Roxicodone®, Percocet®, OxyContin®, Oxaydo®, Xtampza®) for Pain
- Paclitaxel (Taxol®) for Breast Cancer - early stage
- Paclitaxel (Taxol®) + Trastuzumab + Pertuzumab (Perjeta®) for Breast Cancer - early stage
- Paclitaxel + Trastuzumab for Breast Cancer - early stage
- Paclitaxel + Trastuzumab + Pertuzumab for Breast Cancer - metastatic
- Pacritinib (Vonjo®) for Myelofibrosis
- Palbociclib (Ibrance®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Palbociclib (Ibrance®) + Letrozole (Femara®) for Breast Cancer - metastatic
- Palbociclib (Ibrance®) + Anastrozole (Arimidex®) for Breast Cancer - metastatic
- Palonosetron (Aloxi®) for Nausea and Vomiting
- Pazopanib (Votrient®) for Renal Cell Carcinoma - Kidney Cancer
- Pegfilgrastim (Neulasta®, Neulasta OnPro®, Udenyca®, Fulphila®, Ziextenzo®, Nyvepria®, Fylnetra®) for Neutropenic Fever
- Peginterferon alfa-2a (Pegasys®) for Polycythemia Vera
- Pembrolizumab (Keytruda®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) for Melanoma
- Pembrolizumab (Keytruda®) for Bladder Cancer
- Pembrolizumab (Keytruda®) for Head and Neck Cancer
- Pembrolizumab (Keytruda®) for Renal Cell Carcinoma - Kidney Cancer
- Pembrolizumab (Keytruda®) + Abraxane® (Paclitaxel protein-bound particles) for Breast Cancer - metastatic
- Pembrolizumab (Keytruda®) + Carboplatin + Abraxane® (Paclitaxel protein-bound particles) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) + Carboplatin + Paclitaxel for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) + Carboplatin + Pemetrexed (Alimta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pirtobrutinib (Jaypirca®) for Chronic Lymphocytic Leukemia (CLL)
- Pirtobrutinib (Jaypirca®) for Lymphoma, Mantle Cell
- Pola-R-CHP (Polatuzumab Vedotin (Polivy®) + Rituximab + Cyclophosphamide + Doxorubicin + Prednisone) for Lymphoma, B-cell
- Polyethylene Glycol (MiraLAX®) for Constipation
- Pomalidomide (Pomalyst®) for Multiple Myeloma (MM)
- POMP (6-Mercaptopurine + Vincristine + Methotrexate + Prednisone) for Acute Lymphoid Leukemia (ALL)
- Ponatinib (Iclusig®) for Chronic Myeloid Leukemia (CML)
- Ponatinib (Iclusig®) for Acute Lymphoid Leukemia (ALL)
- Prednisone for Immune Thrombocytopenic Purpura (ITP)
- Prochlorperazine (Compazine®) for Nausea and Vomiting
- Promethazine (Phenergan®) for Nausea and Vomiting
- R-CHOP (Rituximab + Cyclophosphamide + Doxorubicin + Vincristine + Prednisone) for Lymphoma, B-cell
- R-CHOP/R-DHAP (Rituximab + Cyclophosphamide + Doxorubicin + Vincristine + Prednisone + Dexamethasone + Cytarabine + Cisplatin) for Lymphoma, Mantle Cell
- R-CVP (Rituximab + Cyclophosphamide + Vincristine + Prednisone) for Lymphoma, B-cell
- R-DHAP (Rituximab + Dexamethasone + Cytarabine + Cisplatin) for Lymphoma, Mantle Cell
- R-GemOx (Rituximab + Gemcitabine + Oxaliplatin) for Lymphoma, B-cell
- Ramucirumab (Cyramza®) for Stomach Cancer
- Ramucirumab (Cyramza®) for Liver Cancer
- Rd (Revlimid® + Dexamethasone) for Multiple Myeloma (MM)
- Regorafenib (Stivarga®) for Colon Cancer
- Regorafenib (Stivarga®) for Liver Cancer
- Ribociclib (Kisqali®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Ribociclib (Kisqali®) + Letrozole (Femara®) for Breast Cancer - metastatic
- Ribociclib (Kisqali®) + Letrozole (Femara®) for Breast Cancer - early stage
- Ribociclib (Kisqali®) + Anastrozole (Arimidex®) for Breast Cancer - metastatic
- Ribociclib (Kisqali®) + Anastrozole (Arimidex®) for Breast Cancer - early stage
- RICE (Rituximab + Ifosfamide + Carboplatin + Etoposide) for Lymphoma, B-cell
- Rituximab (Rituxan®, Truxima®, Ruxience® Riabni®) for Immune Thrombocytopenic Purpura (ITP)
- Rituximab (Rituxan®, Truxima®, Ruxience®, Riabni®) for Chronic Lymphocytic Leukemia (CLL)
- Rituximab + High Dose Methotrexate for Lymphoma, Primary CNS (PCNSL)
- Rituximab + Hyaluronidase (Rituxan Hycela®) for Lymphoma, B-cell
- Rituximab + Lenalidomide (Revlimid®) for Lymphoma, Mantle Cell
- Rituximab + Lenalidomide (Revlimid®) for Lymphoma, B-cell
- Rivaroxaban (Xarelto®) for Blood Clots
- Rolapitant (Varubi®) for Nausea and Vomiting
- Romidepsin (Istodax®) for Lymphoma, T-Cell
- Romiplostim (Nplate®) for Immune Thrombocytopenic Purpura (ITP)
- Rucaparib (Rubraca®) for Ovarian Cancer
- Ruxolitinib (Jakafi®) for Myelofibrosis
- Ruxolitinib (Jakafi®) for Polycythemia Vera
- RVd (Revlimid® + Velcade® + dexamethasone) for Multiple Myeloma (MM)
- Sacituzumab Govitecan (Trodelvy®) for Breast Cancer - metastatic
- Senna + Docusate (Senokot-S®, Senna-S®) for Constipation
- Sipuleucel-t (Provenge®) for Prostate Cancer
- Sorafenib (Nexavar®) for Renal Cell Carcinoma - Kidney Cancer
- Sorafenib (Nexavar®) for Liver Cancer
- Sotorasib (Lumakras®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Sunitinib (Sutent®) for Renal Cell Carcinoma - Kidney Cancer
- Talazoparib (Talzenna®) for Breast Cancer - metastatic
- Tamoxifen for Breast Cancer - early stage
- Tamoxifen (Nolvadex®) for Breast Cancer - metastatic
- TC (Docetaxel + Cyclophos­phamide) for Breast Cancer - early stage
- TCH (Taxotere® + Carboplatin + Herceptin®) for Breast Cancer - early stage
- TCHP (Taxotere® + Carboplatin + Herceptin® + Perjeta®) for Breast Cancer - early stage
- Temozolomide (Temodar®) + Radiation for Brain Cancer
- Temsirolimus (Torisel®) for Renal Cell Carcinoma - Kidney Cancer
- THP (Taxotere® + Herceptin® + Perjeta®) for Breast Cancer - metastatic
- Tisagenlecleucel (Kymriah®) CAR T-Cells for Acute Lymphoid Leukemia (ALL)
- Tisotumab Vedotin (Tivdak®) for Cervical Cancer
- Topotecan (Hycamtin®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Topotecan + Paclitaxel + Bevacizumab for Cervical Cancer
- Trabectedin (Yondelis®) for Sarcoma
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) for Liver Cancer
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) + Carboplatin + Abraxane® for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) + Carboplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) + Cisplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Trifluridine and Tipiracil (Lonsurf®) for Colon Cancer
- Tucatinib (Tukysa®) + Trastuzumab + Capecitabine for Breast Cancer - metastatic
- VAdriaC (Vincristine + Cyclophosphamide + Doxorubicin) + IE (Ifosfamide + Etoposide) for Sarcoma
- Vd (Bortezomib (Velcade®) + Dexamethasone) for Multiple Myeloma (MM)
- Vemurafenib (Zelboraf®) + Cobimetinib (Cotellic®) for Melanoma
- Venetoclax (Venclexta®) + Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- Venetoclax (Venclexta®) + Decitabine (Dacogen®) for Acute Myeloid Leukemia (AML)
- Venetoclax (Venclexta) for Chronic Lymphocytic Leukemia (CLL)
- Venetoclax (Venclexta®) + Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia (CLL)
- VIP (Etoposide + Ifosfamide + Cisplatin) for Testicular Cancer
- VTd (Velcade® + Thalidomide + dexamethasone) for Multiple Myeloma (MM)
- Zanubrutinib (Brukinsa®) for Lymphoma, Mantle Cell
- Zanubrutinib (Brukinsa®) for Chronic Lymphocytic Leukemia (CLL)
Created: December 15, 2015
Updated: September 9, 2019